These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17725809)

  • 21. Principal stratification designs to estimate input data missing due to death.
    Frangakis CE; Rubin DB; An MW; MacKenzie E
    Biometrics; 2007 Sep; 63(3):641-9; discussion 650-62. PubMed ID: 17824995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semiparametric approaches for joint modeling of longitudinal and survival data with time-varying coefficients.
    Song X; Wang CY
    Biometrics; 2008 Jun; 64(2):557-66. PubMed ID: 17725812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subgroup mortality probability models: are they necessary for specialized intensive care units?
    Nathanson BH; Higgins TL; Kramer AA; Copes WS; Stark M; Teres D
    Crit Care Med; 2009 Aug; 37(8):2375-86. PubMed ID: 19531946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scheduling mammography screening for the early detection of breast cancer in Korean women.
    Lee SY; Jeong SH; Kim J; Jung SH; Song KB; Nam CM
    J Med Screen; 2007; 14(4):205-9. PubMed ID: 18078566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models.
    Fiocco M; Putter H; van Houwelingen HC
    Stat Med; 2008 Sep; 27(21):4340-58. PubMed ID: 18425994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
    Lee TA; Schumock GT; Bartle B; Pickard AS
    Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression models for infant mortality data in Norwegian siblings, using a compound Poisson frailty distribution with random scale.
    Moger TA; Aalen OO
    Biostatistics; 2008 Jul; 9(3):577-91. PubMed ID: 18304994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation and prediction system for multi-state disease process: application to analysis of organized screening regime.
    Chang CM; Lin WC; Kuo HS; Yen MF; Chen TH
    J Eval Clin Pract; 2007 Dec; 13(6):867-81. PubMed ID: 18070257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history and effectiveness of early detection of Parkinson's disease: results from two community-based programmes in Taiwan (KCIS no. 11).
    Liou HH; Wu CY; Chiu YH; Yen AM; Chen RC; Chen TF; Chen CC; Hwang YC; Wen YR; Chen TH
    J Eval Clin Pract; 2008 Apr; 14(2):198-202. PubMed ID: 18284524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach.
    Etzioni R; Gulati R; Falcon S; Penson DF
    Med Decis Making; 2008; 28(3):323-31. PubMed ID: 18319508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating average annual percent change for disease rates without assuming constant change.
    Fay MP; Tiwari RC; Feuer EJ; Zou Z
    Biometrics; 2006 Sep; 62(3):847-54. PubMed ID: 16984328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applications of extensions of bivariate rank sum statistics to the crossover design to compare two treatments through four sequence groups.
    Kawaguchi A; Koch GG; Ramaswamy R
    Biometrics; 2009 Sep; 65(3):979-88. PubMed ID: 19173698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-dependent covariates in the proportional subdistribution hazards model for competing risks.
    Beyersmann J; Schumacher M
    Biostatistics; 2008 Oct; 9(4):765-76. PubMed ID: 18434297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flexible statistical models provided new insights into the role of quantitative prognostic factors for mortality in gastric cancer.
    Binquet C; Abrahamowicz M; Astruc K; Faivre J; Bonithon-Kopp C; Quantin C
    J Clin Epidemiol; 2009 Mar; 62(3):232-40. PubMed ID: 19070464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling individual effects in the Cormack-Jolly-Seber model: a state-space formulation.
    Royle JA
    Biometrics; 2008 Jun; 64(2):364-70. PubMed ID: 17725811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.
    Merenich JA; Olson KL; Delate T; Rasmussen J; Helling DK; Ward DG;
    Pharmacotherapy; 2007 Oct; 27(10):1370-8. PubMed ID: 17896892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling disease-state transition heterogeneity through Bayesian variable selection.
    Healy BC; Engler D
    Stat Med; 2009 Apr; 28(9):1353-68. PubMed ID: 19206077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.
    Das A; Singh V; Fleischer DE; Sharma VK
    Am J Gastroenterol; 2008 Jun; 103(6):1340-5. PubMed ID: 18510606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.